Twi Pharms patents expiration
1. Forfivo Xl patents expiration
FORFIVO XL Litigations
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7674479 | TWI PHARMS | Sustained-release bupropion and bupropion/mecamylamine tablets |
Jun, 2027
(3 years from now) | |
Drugs and Companies using BUPROPION HYDROCHLORIDE ingredient
Market Authorisation Date: 10 November, 2011
Treatment: NA
Dosage: TABLET, EXTENDED RELEASE;ORAL
How can I launch a generic of FORFIVO XL before it's drug patent expiration?
More Information on Dosage
FORFIVO XL family patents
2. Naprelan patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5637320 | TWI PHARMS | Controlled absorption naproxen formulation for once-daily administration |
Jun, 2014
(9 years ago) | |
Drugs and Companies using NAPROXEN SODIUM ingredient
Market Authorisation Date: 05 January, 1996
Treatment: NA
Dosage: TABLET, EXTENDED RELEASE;ORAL
How can I launch a generic of NAPRELAN before it's drug patent expiration?
More Information on Dosage
NAPRELAN family patents